Published in Ann Surg on November 01, 1976
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy. Ann Surg (1979) 0.80
The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck. Am J Surg (1974) 2.33
The surgical therapy of malignant melanomas. Semin Oncol (1975) 1.08
The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27
Germline p16 mutations in familial melanoma. Nat Genet (1994) 5.59
Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med (1995) 4.10
THE CLINICAL EVALUATION OF AUREOMYCIN. J Clin Invest (1949) 3.60
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol (1978) 2.81
The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA (1997) 2.65
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol (1975) 2.36
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer (1980) 2.04
The developmental biology of primary human malignant melanomas. Semin Oncol (1975) 1.92
Premarital sex, schoolgirl pregnancy, and school quality in rural Kenya. Stud Fam Plann (2001) 1.91
Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg (1983) 1.89
Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res (1985) 1.85
Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA (1978) 1.74
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Lentigo maligna and lentigo-maligna melanoma. Am J Pathol (1969) 1.68
The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med (1971) 1.65
The dysplastic nevus syndrome: our definition. Am J Dermatopathol (1982) 1.63
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med (1996) 1.62
Biology of tumor progression in human melanocytes. Lab Invest (1987) 1.61
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med (1985) 1.51
The biologic forms of malignant melanoma. Hum Pathol (1986) 1.51
Primary malignant melanoma of the urinary bladder. Cancer (1976) 1.48
Early melanoma. Histologic terms. Am J Dermatopathol (1991) 1.43
Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies. Hum Pathol (1973) 1.36
How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol (1986) 1.34
Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet (1986) 1.34
Malignant melanoma in renal-transplant recipients. Lancet (1981) 1.33
Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. Cancer Res (1980) 1.27
A fine-structure study of the human epidermal melanosome complex and its acid phosphatase activity. J Ultrastruct Res (1968) 1.26
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. J Natl Cancer Inst (1989) 1.23
Malignant melanoma in the Sinclair miniature swine: an autopsy study of 60 cases. Am J Pathol (1979) 1.18
Progressive arterial occlusive disease (Köhlmeier-Degos). A frequently fatal cutaneosystemic disorder. N Engl J Med (1967) 1.17
Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet (1984) 1.15
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol (1984) 1.11
Reactivity of monoclonal anti-melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma. Eur J Immunol (1979) 1.10
The surgical therapy of malignant melanomas. Semin Oncol (1975) 1.08
Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am J Hum Genet (1993) 1.08
Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res (1989) 1.07
Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases. Cancer (1975) 1.05
Expression of DR antigens in freshly frozen human tumors. Hybridoma (1982) 1.05
The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol (1993) 1.03
Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet (1988) 1.03
Effect of fluorouracil on intestinal anastomoses in the rat. Arch Surg (1969) 1.01
Primary choroidal and cutaneous melanomas occurring in a patient with the B-K mole syndrome phenotype. Am J Ophthalmol (1980) 1.01
Dysplastic naevi and cutaneous melanoma risk. Lancet (1983) 0.99
Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr (1983) 0.98
The clinical diagnosis of malignant melanoma. Semin Oncol (1975) 0.98
Relationship between patients' early recognition of melanoma and depth of invasion. Cancer (1982) 0.98
Disorders of the panniculus adiposus. Hum Pathol (1973) 0.98
Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol (1990) 0.97
A t(1;19) chromosome translocation in three cases of human malignant melanoma. Cancer Res (1986) 0.97
Malignant melanoma simulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype. Am J Pathol (1990) 0.97
Molecular phylogeny and biogeography of the marine shrimp Penaeus. Mol Phylogenet Evol (1998) 0.96
Production and characterization of monoclonal antibodies against human malignant melanoma. Cancer Invest (1983) 0.96
The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg (1991) 0.96
Current concepts of the biology of human cutaneous malignant melanoma. Adv Cancer Res (1977) 0.95
Azaphilones with endothelin receptor binding activity produced by Penicillium sclerotiorum: taxonomy, fermentation, isolation, structure elucidation and biological activity. J Antibiot (Tokyo) (1995) 0.94
Comparison of the classification by microscopic level (stage) of malignant melanoma by three independent groups of pathologists. Cancer (1977) 0.94
Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med (1986) 0.93
Dermal squamo-melanocytic tumor: a unique biphenotypic neoplasm of uncertain biological potential. Hum Pathol (1999) 0.92
The cutaneous collagenoses. Hum Pathol (1973) 0.92
A fine structural investigation of surface specializations and the cortical reaction in eggs of the cnidarian Bunodosoma cavernata. J Cell Biol (1974) 0.92
Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma. J Am Acad Dermatol (1987) 0.91
Malignant melanomas of the conjunctiva. Am J Ophthalmol (1976) 0.91
Adenocarcinoma of the small bowel complicating Crohn's disease. Cancer (1970) 0.90
Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol (1991) 0.90
Immunologic competence of regional lymph nodes in patients with breast cancer. Cancer (1975) 0.90
Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med (1985) 0.90
The cutaneous mucinoses. Hum Pathol (1973) 0.90
Fatty acid synthesis by human adipose tissue. Metabolism (1975) 0.90
Association of actin with sperm centrioles: isolation of centriolar complexes and immunofluorescent localization of actin. J Cell Biol (1980) 0.89
Erythema multiforme exudativum: distinctive pathological process. Br J Dermatol (1971) 0.88
Multiple primary melanoma. Cancer (1979) 0.88
The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm). Cancer (1985) 0.88
Growth and phenotypic characteristics of human nevus cells in culture. J Invest Dermatol (1988) 0.88
Studies on the tardigrades. II. Fine structure of the pharynx of Milnesium tardigradum Doyère. Tissue Cell (1973) 0.87
Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors. Am J Pathol (1982) 0.87
Precursor lesions in familial melanoma. Semin Oncol (1978) 0.86
Cryopreservation of sperm from the marine shrimp Sicyonia ingentis. Cryobiology (1988) 0.86
Pilar neurocristic hamartoma. J Am Acad Dermatol (1996) 0.86
Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors. Hybridoma (1985) 0.86
Sun-related risk factors in melanoma-prone families with CDKN2A mutations. J Natl Cancer Inst (1998) 0.86
Melanocytic lesions of the eyelid skin. Am J Ophthalmol (1976) 0.86
Reduced DNA repair in cultured melanocytes and nevus cells from a patient with xeroderma pigmentosum. Arch Dermatol (1989) 0.86